CAS: 1316059-00-3
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | GSK 854 REF: 3D-BG165704CAS: 1316059-00-3 | Min. 95% | 310,00 €~1.971,00 € | Mar 21 Ene 25 |
 | GSK854 REF: TM-T24115CAS: 1316059-00-3 | 98.79% | 95,00 €~3.480,00 € | Mar 28 Ene 25 |
GSK 854
CAS:1316059-00-3
Molecular probe for understanding the biology of troponin I-interacting kinase (TNNI3K) and its role in …
Fórmula:
C18H19ClN6O4S2
Pureza:
Min. 95%
Peso molecular:
482.97 g/mol
Ref: 3D-BG165704
| 1mg | 310,00 € | ||
| 2mg | 465,00 € | ||
| 5mg | 740,00 € | ||
| 10mg | 1.102,00 € | ||
| 25mg | 1.971,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
GSK854
CAS:1316059-00-3
GSK854 is a selective TNNI3K inhibitor reducing heart damage and stress post-infarction in mice.
Fórmula:
C18H19ClN6O4S2
Pureza:
98.79%
Forma y color:
Solid
Peso molecular:
482.96
Ref: TM-T24115
| 1mg | 95,00 € | ||
| 5mg | 230,00 € | ||
| 10mg | 371,00 € | ||
| 25mg | 732,00 € | ||
| 50mg | 1.100,00 € | ||
| 100mg | 1.735,00 € | ||
| 500mg | 3.480,00 € | ||
| 1mL*10mM (DMSO) | 257,00 € |
Entrega estimada en Estados Unidos, el Martes 28 de Enero de 2025
